Details

Product Name in the RMS: Emerpand

MR Number: DK/H/2329/002
Date of outcome: 25.11.2014

Type of application
Level 1: Level 2: Level 3: Level 4: Level 5:	Abridged Additional Strength/Form Generic Chemical Substance Prescription Only
Active Substances	rivastigmine 4,6 mg/24h
Form	Transdermal patch
MA Holder in the RMS	Splitting procedure: New splitted procedure numbers are IE/H/0569/001-003, SI/H/0183/001-003 and PT/H/2144/001-003 Actavis Group PTC ehf. Reykjavíkurvegur 76-78 220 Hafnarfjödur Iceland
RMS	Denmark
Date of last change	28.10.2019
ATC-Code	N06DA03 Rivastigmine

CMS Country	Domestic Product Name
Norway

Documents
PAR:	DK_H_2329_002_PAR.pdf (05.11.2015)
PARSummary:	DK_H_2329_002_PARSummary.pdf (05.11.2015)
FinalLabelling:	DK_H_2329_002_FinalLabelling.pdf (06.11.2018)
Finalised Product Information:	DK_H_2329_002_FinalPI.pdf (08.12.2014)